Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05535062 · ClinicalTrials.gov registry record · NA
Study to Evaluate Treatment Effects Associated With the NeuroStar SoftStart Treatment Feature
A NA study, sponsored by Neuronetics.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT05535062 is a NA study that has completed, run by Neuronetics. The registered enrollment target is 40 participants.
The verdict
NCT05535062, a NA study, has completed, sponsored by Neuronetics.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the comfort of the NeuroStar® Advanced Therapy System regular prescribed TMS protocol versus a New Feature.
Interventions
- DEVICE repetitive Transcranial Magnetic Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-11-07 |
| Est. Completion | 2023-09-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05535062
The ClinicalTrials.gov registry entry for NCT05535062 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neuronetics, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which repetitive Transcranial Magnetic Stimulation is the first listed.
NCT05535062 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05535062 about?
NCT05535062 is a clinical study titled "Study to Evaluate Treatment Effects Associated With the NeuroStar SoftStart Treatment Feature". The purpose of this study is to evaluate the comfort of the NeuroStar® Advanced Therapy System regular prescribed TMS protocol versus a New Feature.
What is the current status of trial NCT05535062?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-11-07. Estimated completion is 2023-09-27.
What interventions are being tested in trial NCT05535062?
The interventions under investigation include: repetitive Transcranial Magnetic Stimulation (DEVICE).
Who is sponsoring clinical trial NCT05535062?
This trial is sponsored by Neuronetics, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.